Copyright Reports & Markets. All rights reserved.

Global Anthrax Vaccines Sales Market Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Global Anthrax Vaccines Sales Market Report 2019

      1 Anthrax Vaccines Market Overview

      • 1.1 Anthrax VaccinesProduct Overview
      • 1.2 Anthrax Vaccines Segment by Type
        • 1.2.1 Global Anthrax Vaccines Sales Comparison by Types (2014-2025)
        • 1.2.2 Cell Free PA Vaccines: Anthrax Vaccine Adsorbed (AVA) , Anthrax Vaccine Precipitated (AVP)
        • 1.2.3 Live Vaccines
      • 1.3 Anthrax Vaccines Segment by Application
        • 1.3.1 Global Anthrax Vaccines Sales Comparison by Application (2014-2025)
        • 1.3.1 Human
        • 1.3.2 Animals
      • 1.4 Anthrax Vaccines Market by Region
        • 1.4.1 Global Anthrax Vaccines Revenue Comparison by Region (2014-2025)
        • 1.4.2 United States Anthrax Vaccines Status and Prospect (2014-2025)
        • 1.4.3 Europe Anthrax Vaccines Status and Prospect (2014-2025)
        • 1.4.4 China Anthrax Vaccines Status and Prospect (2014-2025)
        • 1.4.5 Japan Anthrax Vaccines Status and Prospect (2014-2025)
        • 1.4.6 Southeast Asia Anthrax Vaccines Status and Prospect (2014-2025)
        • 1.4.7 India Anthrax Vaccines Status and Prospect (2014-2025)
      • 1.5 Global Anthrax Vaccines Sales and Revenue (2014-2025)
        • 1.5.1 Global Anthrax Vaccines Sales and Growth Rate (2014-2025)
        • 1.5.2 Global Anthrax Vaccines Revenue and Growth Rate (2014-2025)

      2 Anthrax Vaccines by Company, Region, Type and Application

      • 2.1 Global Anthrax Vaccines Market Competition by Companies
        • 2.1.1 Global Anthrax Vaccines Sales Market Share of Key Companies (2014-2019)
        • 2.1.2 Global Anthrax Vaccines Revenue Market Share by Company (2014-2019)
      • 2.2 Global Anthrax Vaccines Sales and Revenue by Region
        • 2.2.1 Global Anthrax Vaccines Sales Market Share by Region (2014-2019)
        • 2.2.2 Global Anthrax Vaccines Revenue Market Share by Region (2014-2019)
      • 2.3 Global Anthrax Vaccines Sales and Revenue by Type
        • 2.3.1 Global Anthrax Vaccines Sales Market Share by Type (2014-2019)
        • 2.3.2 Global Anthrax Vaccines Revenue Market Share by Type (2014-2019)
      • 2.4 Global Anthrax Vaccines Sales by Application

      3 United States Anthrax Vaccines Sales, Revenue and Price

      • 3.1 United States Anthrax Vaccines Sales and Revenue (2014-2019)
        • 3.1.1 United States Anthrax Vaccines Sales Growth Rate (2014-2019)
        • 3.1.2 United States Anthrax Vaccines Revenue Growth Rate (2014-2019)
        • 3.1.3 United States Anthrax Vaccines Price Trend (2014-2019)
      • 3.2 United States Anthrax Vaccines Sales Market Share by Company
      • 3.3 United States Anthrax Vaccines Sales Market Share by Type
      • 3.4 United States Anthrax Vaccines Sales Market Share by Application

      4 Europe Anthrax Vaccines Sales, Revenue and Price

      • 4.1 Europe Anthrax Vaccines Sales and Value (2014-2019)
        • 4.1.1 Europe Anthrax Vaccines Sales Growth Rate (2014-2019)
        • 4.1.2 Europe Anthrax Vaccines Revenue Growth Rate (2014-2019)
        • 4.1.3 Europe Anthrax Vaccines Price Trend (2014-2019)
      • 4.2 Europe Anthrax Vaccines Sales Market Share by Company
      • 4.3 Europe Anthrax Vaccines Sales Market Share by Type
      • 4.4 Europe Anthrax Vaccines Sales Market Share by Application

      5 China Anthrax Vaccines Sales, Revenue and Price

      • 5.1 China Anthrax Vaccines Sales and Revenue (2014-2019)
        • 5.1.1 China Anthrax Vaccines Sales Growth Rate (2014-2019)
        • 5.1.2 China Anthrax Vaccines Revenue Growth Rate (2014-2019)
        • 5.1.3 China Anthrax Vaccines Price Trend (2014-2019)
      • 5.2 China Anthrax Vaccines Sales Market Share by Company
      • 5.3 China Anthrax Vaccines Sales Market Share by Type
      • 5.4 China Anthrax Vaccines Sales Market Share by Application

      6 Japan Anthrax Vaccines Sales, Revenue and Price

      • 6.1 Japan Anthrax Vaccines Sales and Value (2014-2019)
        • 6.1.1 Japan Anthrax Vaccines Sales Growth Rate (2014-2019)
        • 6.1.2 Japan Anthrax Vaccines Revenue Growth Rate (2014-2019)
        • 6.1.3 Japan Anthrax Vaccines Price Trend (2014-2019)
      • 6.2 Japan Anthrax Vaccines Sales Market Share by Company
      • 6.3 Japan Anthrax Vaccines Sales Market Share by Type
      • 6.4 Japan Anthrax Vaccines Sales Market Share by Application

      7 Southeast Asia Anthrax Vaccines Sales, Revenue and Price

      • 7.1 Southeast Asia Anthrax Vaccines Sales and Value (2014-2019)
        • 7.1.1 Southeast Asia Anthrax Vaccines Sales Growth Rate (2014-2019)
        • 7.1.2 Southeast Asia Anthrax Vaccines Revenue Growth Rate (2014-2019)
        • 7.1.3 Southeast Asia Anthrax Vaccines Price Trend (2014-2019)
      • 7.2 Southeast Asia Anthrax Vaccines Sales Market Share by Company
      • 7.3 Southeast Asia Anthrax Vaccines Sales Market Share by Type
      • 7.4 Southeast Asia Anthrax Vaccines Sales Market Share by Application

      8 India Anthrax Vaccines Sales, Revenue and Price

      • 8.1 India Anthrax Vaccines Sales and Value (2014-2019)
        • 8.1.1 India Anthrax Vaccines Sales Growth Rate (2014-2019)
        • 8.1.2 India Anthrax Vaccines Revenue Growth Rate (2014-2019)
        • 8.1.3 India Anthrax Vaccines Price Trend (2014-2019)
      • 8.2 India Anthrax Vaccines Sales Market Share by Company
      • 8.3 India Anthrax Vaccines Sales Market Share by Type
      • 8.4 India Anthrax Vaccines Sales Market Share by Application

      9 Company Profiles and Key Figures in Anthrax Vaccines Business

      • 9.1 Agrovet
        • 9.1.1 Agrovet Anthrax Vaccines Production Sites and Area Served
        • 9.1.2 Anthrax Vaccines Specification and Application
        • 9.1.3 Agrovet Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.1.4 Main Business and Markets Served
      • 9.2 Bayer Sanidad Animal
        • 9.2.1 Bayer Sanidad Animal Anthrax Vaccines Production Sites and Area Served
        • 9.2.2 Anthrax Vaccines Specification and Application
        • 9.2.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.2.4 Main Business and Markets Served
      • 9.3 Biogénesis-Bago S.A.
        • 9.3.1 Biogénesis-Bago S.A. Anthrax Vaccines Production Sites and Area Served
        • 9.3.2 Anthrax Vaccines Specification and Application
        • 9.3.3 Biogénesis-Bago S.A. Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.3.4 Main Business and Markets Served
      • 9.4 Botswana Vaccine Institute
        • 9.4.1 Botswana Vaccine Institute Anthrax Vaccines Production Sites and Area Served
        • 9.4.2 Anthrax Vaccines Specification and Application
        • 9.4.3 Botswana Vaccine Institute Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.4.4 Main Business and Markets Served
      • 9.5 CAVAC
        • 9.5.1 CAVAC Anthrax Vaccines Production Sites and Area Served
        • 9.5.2 Anthrax Vaccines Specification and Application
        • 9.5.3 CAVAC Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.5.4 Main Business and Markets Served
      • 9.6 Central Veterinary Control and Research Institute
        • 9.6.1 Central Veterinary Control and Research Institute Anthrax Vaccines Production Sites and Area Served
        • 9.6.2 Anthrax Vaccines Specification and Application
        • 9.6.3 Central Veterinary Control and Research Institute Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.6.4 Main Business and Markets Served
      • 9.7 Centro Diagnóstico Veterinario
        • 9.7.1 Centro Diagnóstico Veterinario Production Sites and Area Served
        • 9.7.2 Anthrax Vaccines Specification and Application
        • 9.7.3 Centro Diagnóstico Veterinario Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.7.4 Main Business and Markets Served
      • 9.8 Ceva Sante Animale
        • 9.8.1 Ceva Sante Animale Anthrax Vaccines Production Sites and Area Served
        • 9.8.2 Anthrax Vaccines Specification and Application
        • 9.8.3 Ceva Sante Animale Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.8.4 Main Business and Markets Served
      • 9.9 Colorado Serum Company
        • 9.9.1 Colorado Serum Company Anthrax Vaccines Production Sites and Area Served
        • 9.9.2 Anthrax Vaccines Specification and Application
        • 9.9.3 Colorado Serum Company Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.9.4 Main Business and Markets Served
      • 9.10 Empresa Colombiana de Productos Veterinarios S.A. (Vecol)
        • 9.10.1 Empresa Colombiana de Productos Veterinarios S.A. (Vecol) Anthrax Vaccines Production Sites and Area Served
        • 9.10.2 Anthrax Vaccines Specification and Application
        • 9.10.3 Empresa Colombiana de Productos Veterinarios S.A. (Vecol) Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.10.4 Main Business and Markets Served
      • 9.11 Indian Immunologicals Limited
      • 9.12 Institute for Biological Products
      • 9.13 Institute of Animal Health and Veterinary Biologicals
      • 9.14 Institute of Veterinary Preventive Medicine
      • 9.15 Instituto Rosenbusch S.A.
      • 9.16 Institutul Pasteur
      • 9.17 Intervac (PVT) Ltd.
      • 9.18 Jordan Bio-Industries Center (JOVAC)
      • 9.19 KAKETSUKEN (Chemo-Sero-Therapeutic Research Institute)
      • 9.20 Laboratorio Prondil S.A.
      • 9.21 Laboratorios Laverlam S.A.
      • 9.22 Merial Argentina

      10 Anthrax Vaccines Maufacturing Cost Analysis

      • 10.1 Anthrax Vaccines Key Raw Materials Analysis
        • 10.1.1 Key Raw Materials
        • 10.1.2 Key Raw Materials Price Trend
        • 10.1.3 Key Suppliers of Raw Materials
      • 10.2 Proportion of Manufacturing Cost Structure
      • 10.3 Manufacturing Process Analysis of Anthrax Vaccines
      • 10.4 Anthrax Vaccines Industrial Chain Analysis

      11 Marketing Channel, Distributors and Customers

      • 11.1 Marketing Channel
        • 11.1.1 Direct Marketing
        • 11.1.2 Indirect Marketing
      • 11.2 Anthrax Vaccines Distributors List
      • 11.3 Anthrax Vaccines Customers

      12 Market Dynamics

      • 12.1 Market Trends
      • 12.2 Opportunities
      • 12.3 Market Drivers
      • 12.4 Challenges
      • 12.5 Influence Factors

      13 Anthrax Vaccines Market Forecast

      • 13.1 Global Anthrax Vaccines Sales, Revenue and Price Forecast
        • 13.1.1 Global Anthrax Vaccines Sales Growth Forecast (2019-2025)
        • 13.1.2 Global Anthrax Vaccines Revenue Growth Forecast (2019-2025)
        • 13.1.3 Global Anthrax Vaccines Price Trend Forecast (2019-2025)
      • 13.2 Global Anthrax Vaccines Forecast by Region
        • 13.2.1 Global Anthrax Vaccines Sales Growth Forecast by Region (2019-2025)
        • 13.2.2 Global Anthrax Vaccines Revenue Growth Forecast by Region (2019-2025)
        • 13.2.3 United States Anthrax Vaccines Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.4 Europe Anthrax Vaccines Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.5 China Anthrax Vaccines Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.6 Japan Anthrax Vaccines Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.7 Southeast Asia Anthrax Vaccines Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.8 India Anthrax Vaccines Sales, Revenue Growth Forecast (2019-2025)
      • 13.3 Global Anthrax Vaccines Forecast by Type
        • 13.3.1 Global Anthrax Vaccines Sales Forecast by Type (2019-2025)
        • 13.3.2 Global Anthrax Vaccines Revenue Forecast by Type (2019-2025)
        • 13.3.3 Global Anthrax Vaccines Price Forecast by Type (2019-2025)
      • 13.4 Global Anthrax Vaccines Forecast by Application

      14 Research Findings and Conclusion

        15 Methodology and Data Source

        • 15.1 Methodology/Research Approach
          • 15.1.1 Research Programs/Design
          • 15.1.2 Market Size Estimation
          • 15.1.3 Market Breakdown and Data Triangulation
        • 15.2 Data Source
          • 15.2.1 Secondary Sources
          • 15.2.2 Primary Sources
        • 15.3 Author List

        The global Anthrax Vaccines market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report studies the global Anthrax Vaccines market status and forecast, categorizes the global Anthrax Vaccines market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

        Major manufacturers covered in this report
        Agrovet
        Bayer Sanidad Animal
        Biogénesis-Bago S.A.
        Botswana Vaccine Institute
        CAVAC
        Central Veterinary Control and Research Institute
        Centro Diagnóstico Veterinario
        Ceva Sante Animale
        Colorado Serum Company
        Empresa Colombiana de Productos Veterinarios S.A. (Vecol)
        Indian Immunologicals Limited
        Institute for Biological Products
        Institute of Animal Health and Veterinary Biologicals
        Institute of Veterinary Preventive Medicine
        Instituto Rosenbusch S.A.
        Institutul Pasteur
        Intervac (PVT) Ltd.
        Jordan Bio-Industries Center (JOVAC)
        KAKETSUKEN (Chemo-Sero-Therapeutic Research Institute)
        Laboratorio Prondil S.A.
        Laboratorios Laverlam S.A.
        Merial Argentina

        In view of regional level, this report covers
        United States
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Cell Free PA Vaccines: Anthrax Vaccine Adsorbed (AVA) , Anthrax Vaccine Precipitated (AVP)
        Live Vaccines

        Segment by Application
        Human
        Animals

        Buy now